BMC Public Health (Mar 2024)

Cost-related medication nonadherence in adults with COPD in the United States 2013–2020

  • Xin Wen,
  • Hongbin Qiu,
  • Bo Yu,
  • Jinfeng Bi,
  • Xia Gu,
  • Yiying Zhang,
  • Shanjie Wang

DOI
https://doi.org/10.1186/s12889-024-18333-z
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Background Cost-related medication nonadherence (CRN) is associated with poor prognosis among patients with chronic obstructive pulmonary disease (COPD), a population that requires long-term treatment for secondary prevention. In this study, we aimed to estimate the prevalence and sociodemographic characteristics of CRN in individuals with COPD in the US. Methods In a nationally representative survey of US adults in the National Health Interview Survey (2013–2020), we identified individuals aged ≥18 years with a self-reported history of COPD. Cross-sectional study. Results Of the 15,928 surveyed individuals, a weighted 18.56% (2.39 million) reported experiencing CRN, including 12.50% (1.61 million) missing doses, 13.30% (1.72 million) taking lower than prescribed doses, and 15.74% (2.03 million) delaying filling prescriptions to save costs. Factors including age < 65 years, female sex, low family income, lack of health insurance, and multimorbidity were associated with CRN. Conclusions In the US, one in six adults with COPD reported CRN. The influencing factors of CRN are multifaceted and necessitating more rigorous research. Targeted interventions based on the identified influencing factors in this study are recommended to enhance medication adherence among COPD patients.

Keywords